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Abstract
Objective
To evaluate by manometry the esophageal motility changes in patients with primary Sjögren’s syndrome (SS).
Methods
Esophageal manometry was carried out in 25 (F/M: 22/3) primary SS patients with systemic manifestations
and in 42 control subjects. The primary SS patients also completed a dysphagia scoring questionnaire and
underwent whole salivary flow measurements.
Results
As compared with the controls the primary SS patients exhibited a decreased lower esophageal sphincter
(LES) pressure (p < 0.01) and a prolongation of LES relaxations (p < 0.02). In the esophageal body (EB) 
a decreased peristaltic velocity (p < 0.01), an increased duration of contractions (p < 0.01) and a higher 
occurrence of simultaneous waves (p < 0.01) were detected. 
Since decreased peristaltic velocity was the most frequent motor abnormality (11/25 cases), two groups of
patients were formed for further analysis: patients with a decreased (group I, n = 11) and patients with a nor-
mal (group II, n = 14) peristaltic velocity. The SS patients with a decreased EB propagation velocity (  2.7
cm/s, group I) displayed more significantly decreased pressures (p < 0.01) and more prolonged relaxation
times (p < 0.05) in the LES, with higher rates of simultaneous contractions on dry swallows (p = 0.05) in the
EB, as compared with those who had a normal peristaltic velocity (group II). Of the clinical parameters, the
decreased EB peristaltic velocity was associated with a smaller whole saliva production both in the basal
state and after stimulation. Furthermore, this group of patients had a significantly higher liquid requirement
for swallowing than those who had normal peristaltic velocities (p = 0.05).
Conclusions
Primary SS patients with systemic manifestations exhibit several esophageal motility abnormalities. In this
study, a decreased EB peristaltic velocity was the most common manometric change, and showed an 
association with impaired saliva production and higher liquid requirement for swallowing, but not with the 
laboratory parameters or with the systemic manifestations of the disease.
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Introduction
Primary Sjögren’s syndrome (SS) is a
chronic autoimmune inflammatory dis-
order of unknown etiology. The obli-
gatory involvement of the salivary and
l a c rimal glands results in xe ro s t o m i a
and keratoconjunctivitis sicca. Besides
these local glandular manife s t at i o n s ,
other organs (e.g. gastrointestinal, res-
piratory tract, joints, etc.) are often af-
fected (1,2). Although the patients of-
ten complain of difficulties in swallow-
ing, to date only a few studies have
been performed to evaluate the esopha-
geal motor function in the disease (3-
8).
The aim of our study was to conduct a
manometric assessment of esophageal
motility changes in patients with pri-
mary SS.
Materials and methods
Patient population
Twe n t y - five pri m a ry SS patients (22
women, 3 men) with systemic symp-
toms were studied in 1997 and 1998.
All of these patients met the criteria of
the European Community Study Group
(9). At the time of the examination, the
mean age was 55 (range 31-75) years,
and the mean duration of the disease
was 14 (range 2-30) years. The mano-
metric examinations were performed in
random sequence reflecting the visits
of the patients to our outpatient unit, in
all of those patients who agreed to the
investigations and who gave their sign-
ed informed consent.
Esophageal manometric study
E s o p h ageal motility was inve s t i gat e d
after an ove rnight fasting peri o d, by
s t a n d a rd, wat e r-perfusion esophage a l
manometry in each subject, in a recum-
bent position (Polygraph HR, Synectics
Medical, Sweden) according to the pro-
tocol of Castell (10-12). For the proce-
dure, a four-channel, low-compliance,
n a s o e s o p h ageal catheter was ap p l i e d.
The competence of the lower esopha-
geal sphincter (LES) was estimated by
a station pull-through technique. Eso-
phageal body (EB) function was stud-
ied by measuring the amplitude, dura-
tion and pro p agation velocity of the
contractions, and the frequency of si-
multaneous waves after wet (5 cm3 of
room-temperature tap water) and dry
swallows. Ten swallows of each type
we re perfo rmed at least 30 seconds
apart. In the upper esophageal sphinc-
ter (UES), the pre s s u re pro file and
relaxation were studied. In the pharynx
(PHX) the amplitude of the contrac-
tions was measured, with analysis of
the UES-PHX coordination. Polygram
UGI edition 5.06C2 (Gastrosoft Inc.,
S weden) softwa re was used for the
computer-assisted analysis of the trac-
ings. 
The control group (n = 42) for the
manometric examinations consisted of
h e a l t hy vo l u n t e e rs and of pat i e n t s
admitted to the hospital because of
minor abdominal complaints, who did
not exhibit any upper gastrointestinal
symptoms, all of whom likewise gave
their signed informed consent. These
latter patients did not suffer from meta-
bolic disorders or autoimmune connec-
tive tissue diseases. The normal ranges
obtained from these controls (mean ±
S D, see Table II for details) corre-
sponded to the internationally accepted
values (13). 
During the evaluation of EB function,
the results were considered pathologic
ove rall only when ab n o rmal va l u e s
were present at all 4 points: 3, 8,13 and
18 cm ab ove the LES, re s p e c t ive ly.
Prior to the manometric examinations,
the presence of organic esophageal dis-
eases (webs, strictures and malignan-
cies) was excluded by upper gastroin-
testinal endoscopy in all cases.
Symptom analysis
On the day of the manometric study,
the patients were requested to complete
a symptom scoring questionnaire in
relation to their swallowing problems.
S wa l l owing diffi c u l t y, i . e. dy s p h agi a ,
c o m p rises symptoms ra n ging from a
moderate sensation of slowing of the
esophageal passage to the typical feel-
ing of the sticking of solid foods or
even liquids. The patients were asked
about the typical site (from the mouth
to the cardia) and the frequency of dys-
phagia (0: no dysphagia; 1: less than
one episode of dysphagia/week; 2: one
or more episodes of dysphagia/week,3:
one or more episodes of dy s p h agi a /
day; 4: one or more episodes of dys-
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phagia/meal; and 5: problems at each
swallow), the quality of food sticking
( s o l i d s , liquids or both), the typical
food causing a symptom, the require-
ment of liquid for swallowing (0: never,
1: sometimes, and 2: always), the pres-
ence of odynophagia (pain associated
with swa l l owing) (0: n eve r, 1 : o c c a-
sionally, and 2: regularly), and the fre-
quency of aspiration during a meal (0:
never, 1: less than one episode/ week,
2: one or more episodes/week, 3: one
or more episodes/day, and 4: one or
more episodes/meal).
Evaluation of salivary function
Both the unstimulated (basal) and the
s t i mu l ated whole saliva pro d u c t i o n
were measured in all patients. The sali-
vation test was carried out under stan-
dardized conditions between 9 and 11
a.m. Patients we re instructed to fa s t
b e fo re the pro c e d u re. Neither eat i n g
nor drinking nor smoking was allowed
for at least 1 1/2 hours before the saliva
collection. 
For the study, a sterile absorbent gauze
was placed between the lower lip and
the teeth of the patient, who was sitting
in an upright position leaning slightly
forward. Patients were not allowed to
swallow, masticate or speak during the
ex a m i n ation. Both unstimu l ated and
stimulated whole saliva collection last-
ed for 10 minutes. During the stimulat-
ed saliva production, 1 drop of 2% cit-
ric acid solution was placed on the sur-
face of the tongue at the beginning and
in the fifth minute of the examination. 
The difference in the weights of the
gauze before and after the procedures
gave the amount of saliva pro d u c e d.
When the methods we re establ i s h e d
earlier, we also determined the saliva
production in 96 non-SS subjects. With
our method, the unstimu l ated saliva
production is considered to be reduced
if it is £1.0 ml in 10 minutes, and the
s t i mu l ated production is ab n o rm a l ly
low if it is £4.0 ml in 10 minutes.
Histology
A lower lip biopsy was performed in 23
of the 25 patients for histological ex-
amination of the minor salivary glands.
The result was considered positive if at
least one focus of ‡ 50 mononuclear
i n fl a m m at o ry cells per 4 mm2 wa s
found (9). The lip biopsies were carried
out several months or even years prior
to this esophageal manometric study.
Laboratory investigations
Routine lab o rat o ry and immu n o s e ro-
l ogical ex a m i n ations we re perfo rm e d
in all pat i e n t s : a n t i nu clear antibody
( A NA; indirect immu n o fl u o re s c e n c e
on rat liver substrate), IgM rheumatoid
factor (lat ex test, p o s i t ive if titer ‡
1 : 4 0 ) , a n t i - n at ive DNA (ra d i o i m mu-
n o a s s ay ) , a n t i - S S A , a n t i - S S B, a n t i -
RNP and anti-Sm antibodies (enzyme-
linked immunosorbent assay; Immuno
DOT), and concentrations of comple-
ment C3 (rocket immunoelectrophore-
sis).
Statistics
The chi-square test and Student’s t-test
were used for statistical analysis. The
latter was applied with the Welch cor -
rection if the variances differed.
Results
Of the main clinical manife s t at i o n s
which appeared during the course of
the disease, p a rotid enlargement oc-
curred in 15 of the 25 patients (60%),
articular involvement in 19 (76%), pur-
pura in 7 (28%) and Raynaud’s phe-
nomenon in 13 (52%). Renal tubular
acidosis was diagnosed in 7 pat i e n t s
(28%), including 2 patients with histo-
l ogi c a l ly proved tubu l o i n t e rstitial ne-
phritis. Lower airway involvement was
found in 10 patients (40%), with lung
fibrosis in 7 (mild in 5, advanced in 2)
of the 10, verified by high-resolution
computed tomography. 
Of the laboratory changes, leukopenia
(with or without anemia) was detected
in 13 cases (52%), hypergammaglobu-
linemia in 15 (60%), IgM rheumatoid
factor positivity in 23 (92%) and ANA
positivity in 15 (60%). Anti-SSA anti-
body positivity was found in 20 (80%)
patients [alone in 8 (32%), and coupled
with anti-SSB antibody positivity in 12
(48%)] and anti-SSB antibody positi-
vity in 13 (52%) cases [alone in 1 (4%)
and together with anti-SSA antibody
positivity in 12 (48%)]. The histology
of the minor salivary glands was indi-
cative of SS in all biopsied patients.
The symptom evaluation revealed some
grade of dysphagia [score: 2.7 ± 1.37
(mean ± SD)] in all but 2 pat i e n t s
( 2 3 / 2 5 , 92%) (Table I). Of these 23
patients, 22 had swallowing difficulties
for only solids, and 1 for both solids
and liquids. The patients predominant-
ly stated that their dysphagia was situ-
ated in the upper esophageal (9/23) or
p h a ry n geal region (5/23), wh e re a s
symptoms relating to the mid-esopha-
gus were reported in 4/23 cases. 
The most typical foods causing swal-
lowing problems were bread and other
bakery products (17/23, 74%). Meat or
other solid foods (fruits,potato, cheese,
e t c.) we re rep o rted less fre q u e n t ly
(6/23, 26%). All but one patient with
dysphagia needed the aid of liquids to
help them swa l l ow solids, 17 had a
constant, and 5 an occasional need for
this (score: 1.68 ± 0.56 mean ± SD).
Episodes of odynophagia occurred in
11 of the 25 patients (in 5 regularly and
in 6 occasionally ) , giving an ove ra l l
s c o re of 0.67 ± 0.82 (mean ± SD).
Aspiration was rare. At least daily epi-
sodes were reported by only 1 patient,
and 3 patients had we e k ly ep i s o d e s
(score: 0.58 ± 0.88, mean ± SD).
Both basal and stimulated saliva pro-
duction were reduced in 23/25 (92%)
patients. One patient displayed an im-
pairment of stimulated secretion only.
Normal saliva secretion was detected in
1 patient.
Of the studied manometric parameters,
the mean LES pressures were signifi-
cantly lower (p < 0.01), and the relax-
ation times we re signifi c a n t ly pro-
longed (p < 0.02) as compared with the
controls (Table II). However abnormal-
ly low LES pressures were found in
9/25, and prolonged relaxation in 8/25
cases.
In the EB, an increased duration of
p e ristaltic contra c t i o n s , a decre a s e d
propagation velocity and a higher rate
of simultaneous contractions we re
observed for dry and wet swallows (p <
0.01, Table II). The duration of peri-
staltic contractions was ab n o rm a l ly
long in 10/25 cases for wet swallows,
and less frequently (7/25) for dry swal-
lows. The rate of simultaneous contrac-
tions exceeded the normal rate in 7
p atients for wet swa l l ow s , and in 4
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patients for dry swallows. The rate of
simultaneous contractions for dry swal-
lows correlated with the frequency of
dysphagia. Patients with at least daily
episodes of dysphagia (score ³ 3) had
s i g n i fi c a n t ly more simultaneous con-
tractions for dry swallows, than those
with fewer episodes (score £ 2). The
rates were 19.7 ± 25.5% vs. 3.3 ± 7.1%,
(mean ± SD), p < 0.05, respectively.
This difference was not seen for wet
swallows. Concerning the amplitude of
the peristaltic waves, the values for the
patients appeared to be similar to those
for the controls. 
In the upper region of the esophagus(at
the level of the UES and the PHX) the
manometric standards indicated no dif-
ferences in the studied parameters be-
tween the primary SS patients and the
controls (Table II). 
As a decreased EB peristaltic velocity
was the predominant motor abnormali-
ty, two groups of patients were formed
for further study : those with norm a l
and those with abnormal values (Table
III). In group I (11 pat i e n t s ) , e a ch
patient had a decreased (£  2.7 cm/s)
e s o p h ageal peristaltic ve l o c i t y, wh i l e
the patients in group II (14 patients)
had normal values. The LES pressure
was found to be significantly lower (p
< 0.01) and the LES relaxation signifi-
cantly longer (p < 0.05) in group I than
in group II. We also observed a higher
rate of simultaneous contractions in the
EB in group I for dry swallows (p =
0.05), whereas this difference was not
seen for wet swallows. There was no
statistical difference between the two
groups as concerns the values of the
amplitude and duration of the EB con-
traction, and the studied parameters of
the UES-PHX region.
Both the unstimulated and the stimulat-
ed whole saliva production were signif-
icantly lower in group I (p < 0.05 for
both) than in group II (Table IV).
The ch a ra c t e ristics of the dy s p h agi a
were identical in the two groups, with
the ex c eption of one para m e t e r : t h e
group I patients had a signifi c a n t ly
higher liquid requirement for swallow-
ing than the patients in group II, with
scores of 1.91 ± 0.30 vs. 1.50 ± 0.65;
(mean ± SD), p = 0.05, respectively
(Table IV).
The distributions of the systemic mani-
festations of primary SS, the results of
routine and immunological laboratory
tests and the studied demographic para-
meters (age and duration of the disease)
did not demonstrate any stat i s t i c a l ly
significant difference between the two
groups.
Discussion
Although swa l l owing difficulties are
common in patients with primary SS,
the first report on esophageal abnor-
Table I. Distribution of different locations
of dysphagia in patients with primary SS.
Dysphagia No. of pts.
Present 23/25 (92%)
Location
Mouth 3/23 (13%)
Pharynx 5/23 (22%)
Upper third of esophagus 9/23 (39%)
Middle third of esophagus 4/23 (17%)
Lower third of  esophagus 1/23 (4.5%)
Cardia/diaphragm 1/23 (4.5%)
Table II. Manometric differences in esophageal motility between primary SS patients and
controls (mean  ±  SD).
LES Primary SS (n = 25) Control (n = 42) p
Pressure (mm Hg)* 20 ± 8 26 ± 7 < 0.01
Relaxation time (s) 9.7 ± 2.1 8.6 ± 1.4 < 0.02
EB peristaltic wave DS WS DS WS DS WS
Duration above the LES (s) at
3 cm. 4.7 ± 1.1 4.8 ± 0.8 3.6 ± 1.0 3.7 ± 0.9 < 0.01 < 0.01
8 cm. 4.5 ± 1.1 4.7 ± 0.9 3.2 ± 0.8 3.4 ± 0.7 < 0.01 < 0.01
13 cm. 4.0 ± 0.9 3.9 ± 0.7 3.2 ± 0.7 3.1 ± 0.6 < 0.01 < 0.01
18 cm. 3.3 ± 0.7 3.5 ± 1.0 2.5 ± 0.7 2.6 ± 0.6 < 0.01 < 0.01
Propagation velocity (cm/s) 2.8 ± 0.8 2.6 ± 0.6 3.7 ± 0.9 3.3 ± 0.6 < 0.01 < 0.01
Simultaneous contractions (%) 14 ± 22 10 ± 12 5 ± 12 1 ± 3 0.05 < 0.01
Amplitude above the LES (mm Hg) at
3 cm. 71 ± 38 105 ± 40 86 ± 35 113 ± 34 ns ns
8 cm. 69 ± 35 92 ± 35 66 ± 35 99 ± 29 ns ns
13 cm. 53 ± 31 67 ± 30 50 ± 22 65 ± 26 ns ns
18 cm. 41 ± 30 46 ± 30 51 ± 35 59 ± 32 ns ns
UES  Pressure (mmHg)* 66 ± 27 73 ± 29 ns
Relaxation time (s) 1.43 ± 0.39 1.54 ± 0.31 ns
PHX  Contraction amplitude (mm Hg) 45 ± 15 42 ± 16 ns
UES-PHX Coordination (s) -0.15 ± 0.09 -0.15 ± 0.05 ns
LES: lower esophageal sphincter; EB: esophageal body; DS: dry swallow; WS: wet s wallow; UES:
upper esophageal sphincter; PHX: pharynx; ns: not significant. 
* Mean pressure in high-pressure zone of sphincter.
Table III. Manometric abnormalities associated with an impaired EB peristaltic velocity in
patients with primary SS.
Group I Group II
Impaired ( £  2.7 cm/s) Normal (> 2.7 cm/s) P
EB peristaltic velocity EB peristaltic velocity 
(n=11) (n=14)
LES pressure (mm Hg, mean ± SD) 15 ± 6 24 ± 8 < 0.01
LES relaxation time (s, mean ± SD) 10.7 ± 2.5 9.0 ± 1.4 < 0.05
Rate of simultaneous contractions in EB DS: 25 ± 29 DS: 6 ± 6 0.05
(%, mean ± SD) WS: 10 ± 14 WS: 10 ± 11 ns
EB: esophageal body; DS: dry swallow; WS: wet swallow; ns: not significant.
malities was published only in 1967
(5). Since then, a number of studies
have been carried out, but the results
are still controversial. The high preva-
lence of dysphagia is explained as a
consequence either of the lack of saliva
or of esophageal dysmotility (3-5, 8,
14). Less often, in approximately 10%
of the cases, upper esophageal web s
have also been reported (5, 6). In con-
t ra s t , e s o p h ageal motility measure-
ments failed to reveal any specific dys-
motility patterns in SS (3-5, 7). Grande
et al. found no manometric differences
between SS patients and controls, ex-
cept for a decrease in the distal esopha-
geal peristaltic velocity for dry swal-
l ows in SS patients with dy s p h agi a .
Their other finding, that patients with
SS have a signifi c a n t ly higher LES
pressure than controls, may be ques-
t i o n abl e, since their value (15.6 mm
Hg) was at the lower end of the inter-
n at i o n a l ly accepted normal ra n ge (4,
13). Anselimo et al. studied 27 patients
and detected only an increased number
of simultaneous contractions wh e n
severe dysphagia was present (3). In
contrast, Palma et al . observed no sig-
nificant differences in EB motility (7).
Our results are in accordance with the
literature as regards the prevalence of
dysphagia (70-90%) in primary SS. On
the other hand, we observed an im-
paired EB peristaltic velocity in nearly
half of the patients (44%), which ap-
peared to be the predominant esopha-
geal motor abnormality. This alteration
was coupled with a mild decrease in the
LES pressure and a prolongation of the
LES re l a x ation time, wh i ch has not
been described previously. 
We must note that the absolute values
of LES pre s s u re and re l a x ation time
were on the borderline of the interna-
t i o n a l ly accepted normal ra n ges (13)
and the normal ranges in our laborato-
ry. Additionally, other esophageal mo-
tor abnormalities, such as a prolonged
duration of peristaltic contractions and
an increased rate of simultaneous con-
tractions in the EB, were also found in
our patients. Most of our patients had a
markedly diminished salivary function,
which was even more prominent in the
group with an impaired esophage a l
peristaltic velocity. Anselimo et al. (3)
did not find a correlation between sali -
va production and esophageal motor
d i s o rd e rs. The diffe rence from our
results could be explained by the less
markedly diminished saliva production
in their patients, and/or by the fact that
the various parameters in the esopha-
geal motility measurements were not
compared individually with the saliva
production.
Similarly as in the series of other inves-
tigators, the manometric abnormalities
of the esophageal function did not cor-
relate with the presence of the different
systemic manifestations, the laboratory
findings or the demographic parame-
ters of our primary SS patients. The
questionnaire analysis revealed a high-
er liquid requirement for swallowing in
p atients with an impaired peri s t a l t i c
velocity and saliva production. Th i s
s u ggests that both esophageal motor
ab n o rmalities and a diminished sali-
vary function are factors in the devel-
opment of swa l l owing difficulties in
primary SS. As there are data indicat-
ing a parasympathetic dysfunction in
SS (15), its role in the development of
an esophageal motor disturbance and/
or decreased saliva production can not
be ruled out.
To summari ze, our ex a m i n ations re-
vealed that several esophageal motility
abnormalities can be found in primary
SS patients with systemic manifesta-
tions. A decreased EB peristaltic veloc-
ity was the most common manometric
change, which showed an association
with the impaired saliva production and
with the higher liquid requirement for
swallowing, but not with the laboratory
parameters or the systemic manifesta-
tions of the disease.
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